<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.4.555">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Translational Bioinformatics for Immunogenomics - 7&nbsp; Specific Drugs</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./bioinformatic-best-practices.html" rel="next">
<link href="./delayed-drug-allergy.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-KMNNS24XZ5"></script>

<script type="text/javascript">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-KMNNS24XZ5', { 'anonymize_ip': true});
</script>
<link href="site_libs/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet">
<script src="site_libs/htmlwidgets-1.6.4/htmlwidgets.js"></script>
<script src="site_libs/plotly-binding-4.10.4/plotly.js"></script>
<script src="site_libs/typedarray-0.1/typedarray.min.js"></script>
<script src="site_libs/jquery-3.5.1/jquery.min.js"></script>
<link href="site_libs/crosstalk-1.2.1/css/crosstalk.min.css" rel="stylesheet">
<script src="site_libs/crosstalk-1.2.1/js/crosstalk.min.js"></script>
<link href="site_libs/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css" rel="stylesheet">
<script src="site_libs/plotly-main-2.11.1/plotly-latest.min.js"></script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
        <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./drug-allergy.html">Drug Allergy</a></li><li class="breadcrumb-item"><a href="./specific-drugs.html"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Specific Drugs</span></a></li></ol></nav>
        <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
        </a>
      <button type="button" class="btn quarto-search-button" aria-label="" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal quarto-sidebar-collapse-item sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Translational Bioinformatics for Immunogenomics</a> 
        <div class="sidebar-tools-main">
    <a href="https://github.com/mattkrantz/tb4i/" title="Source Code" class="quarto-navigation-tool px-1" aria-label="Source Code"><i class="bi bi-github"></i></a>
  <a href="" class="quarto-reader-toggle quarto-navigation-tool px-1" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
</div>
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Welcome</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./intro.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Introduction</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./hla.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Human Leukocyte Antigens</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./functional-divergence.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Functional Divergence</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hla-imputation-programs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">HLA Imputation Programs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./kir.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Killer Cell Immunoglobulin-like Receptors</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./kir-imputation-programs.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">KIR Allele Imputation Programs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./erap.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">ERAP</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./erap-imputation.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">ERAP Imputation</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./bonus.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Bonus</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Drug Allergy</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./immediate-drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Immediate Drug Allergy</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./delayed-drug-allergy.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Delayed Drug Allergy</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./specific-drugs.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Specific Drugs</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./bioinformatic-best-practices.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Bioinformatic Best Practices</span></a>
          <a class="sidebar-item-toggle text-start collapsed" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="false" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 ">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./reproducible-data-analysis-workflow.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Reproducible Data Analysis Workflow</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./project-organization.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Project Organization</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./file-naming-conventions.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">File Naming Conventions</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./package-managers.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Package Managers</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./version-control-with-git.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Version Control with Git</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./rmarkdown.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Dynamic Document Generation with RMarkdown</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./make.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Dependency Management with Make</span></span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./docker.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">Containerization with Docker</span></span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./genotype-imputation.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Genotype Imputation</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./presenting-your-medical-research.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Presenting Your Medical Research</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./on-being-a-physician-scientist.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">On Being a Physician-Scientist</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Annotated References</span></a>
  </div>
</li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" class="quarto-sidebar-collapse-item" data-bs-toggle="collapse" data-bs-target=".quarto-sidebar-collapse-item"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#antibiotics" id="toc-antibiotics" class="nav-link active" data-scroll-target="#antibiotics">Antibiotics</a>
  <ul>
  <li><a href="#cephalosporins" id="toc-cephalosporins" class="nav-link" data-scroll-target="#cephalosporins">Cephalosporins</a></li>
  <li><a href="#fluoroquinolones" id="toc-fluoroquinolones" class="nav-link" data-scroll-target="#fluoroquinolones">Fluoroquinolones</a></li>
  <li><a href="#macrolides" id="toc-macrolides" class="nav-link" data-scroll-target="#macrolides">Macrolides</a>
  <ul class="collapse">
  <li><a href="#background" id="toc-background" class="nav-link" data-scroll-target="#background">Background</a></li>
  <li><a href="#skin-testing" id="toc-skin-testing" class="nav-link" data-scroll-target="#skin-testing">Skin Testing</a></li>
  <li><a href="#oral-challenge" id="toc-oral-challenge" class="nav-link" data-scroll-target="#oral-challenge">Oral Challenge</a></li>
  </ul></li>
  <li><a href="#penicillins" id="toc-penicillins" class="nav-link" data-scroll-target="#penicillins">Penicillins</a>
  <ul class="collapse">
  <li><a href="#background-1" id="toc-background-1" class="nav-link" data-scroll-target="#background-1">Background</a></li>
  <li><a href="#skin-testing-1" id="toc-skin-testing-1" class="nav-link" data-scroll-target="#skin-testing-1">Skin Testing</a></li>
  </ul></li>
  <li><a href="#sulfa-antibiotics" id="toc-sulfa-antibiotics" class="nav-link" data-scroll-target="#sulfa-antibiotics">Sulfa Antibiotics</a></li>
  <li><a href="#vancomycin" id="toc-vancomycin" class="nav-link" data-scroll-target="#vancomycin">Vancomycin</a></li>
  </ul></li>
  <li><a href="#antiepileptic-drugs" id="toc-antiepileptic-drugs" class="nav-link" data-scroll-target="#antiepileptic-drugs">Antiepileptic Drugs</a>
  <ul>
  <li><a href="#background-2" id="toc-background-2" class="nav-link" data-scroll-target="#background-2">Background</a></li>
  </ul></li>
  <li><a href="#buproprion" id="toc-buproprion" class="nav-link" data-scroll-target="#buproprion">Buproprion</a></li>
  <li><a href="#iron" id="toc-iron" class="nav-link" data-scroll-target="#iron">Iron</a>
  <ul>
  <li><a href="#background-3" id="toc-background-3" class="nav-link" data-scroll-target="#background-3">Background</a></li>
  <li><a href="#immediate-hypersensitivity-reactions" id="toc-immediate-hypersensitivity-reactions" class="nav-link" data-scroll-target="#immediate-hypersensitivity-reactions">Immediate Hypersensitivity Reactions</a></li>
  <li><a href="#minor-infusion-reactions" id="toc-minor-infusion-reactions" class="nav-link" data-scroll-target="#minor-infusion-reactions">Minor Infusion Reactions</a></li>
  <li><a href="#skin-testing-2" id="toc-skin-testing-2" class="nav-link" data-scroll-target="#skin-testing-2">Skin Testing</a></li>
  <li><a href="#management" id="toc-management" class="nav-link" data-scroll-target="#management">Management</a></li>
  <li><a href="#references" id="toc-references" class="nav-link" data-scroll-target="#references">References</a></li>
  </ul></li>
  <li><a href="#local-anesthetics" id="toc-local-anesthetics" class="nav-link" data-scroll-target="#local-anesthetics">Local Anesthetics</a></li>
  <li><a href="#nonsteroidal-anti-inflammatory-drugs" id="toc-nonsteroidal-anti-inflammatory-drugs" class="nav-link" data-scroll-target="#nonsteroidal-anti-inflammatory-drugs">Nonsteroidal Anti-Inflammatory Drugs</a>
  <ul>
  <li><a href="#background-4" id="toc-background-4" class="nav-link" data-scroll-target="#background-4">Background</a></li>
  <li><a href="#management-1" id="toc-management-1" class="nav-link" data-scroll-target="#management-1">Management</a></li>
  <li><a href="#oral-challenge-1" id="toc-oral-challenge-1" class="nav-link" data-scroll-target="#oral-challenge-1">Oral Challenge</a></li>
  </ul></li>
  <li><a href="#radiocontrast" id="toc-radiocontrast" class="nav-link" data-scroll-target="#radiocontrast">Radiocontrast</a>
  <ul>
  <li><a href="#background-5" id="toc-background-5" class="nav-link" data-scroll-target="#background-5">Background</a></li>
  <li><a href="#infusion-reactions" id="toc-infusion-reactions" class="nav-link" data-scroll-target="#infusion-reactions">Infusion Reactions</a></li>
  <li><a href="#immediate-hypersensitivity-reactions-1" id="toc-immediate-hypersensitivity-reactions-1" class="nav-link" data-scroll-target="#immediate-hypersensitivity-reactions-1">Immediate Hypersensitivity Reactions</a></li>
  <li><a href="#delayed-hypersensitivity-reactions" id="toc-delayed-hypersensitivity-reactions" class="nav-link" data-scroll-target="#delayed-hypersensitivity-reactions">Delayed Hypersensitivity Reactions</a></li>
  <li><a href="#skin-testing-3" id="toc-skin-testing-3" class="nav-link" data-scroll-target="#skin-testing-3">Skin Testing</a></li>
  <li><a href="#intravenous-challenge" id="toc-intravenous-challenge" class="nav-link" data-scroll-target="#intravenous-challenge">Intravenous Challenge</a></li>
  <li><a href="#management-2" id="toc-management-2" class="nav-link" data-scroll-target="#management-2">Management</a></li>
  </ul></li>
  <li><a href="#topicals" id="toc-topicals" class="nav-link" data-scroll-target="#topicals">Topicals</a>
  <ul>
  <li><a href="#antibiotics-1" id="toc-antibiotics-1" class="nav-link" data-scroll-target="#antibiotics-1">Antibiotics</a></li>
  <li><a href="#anesthetics" id="toc-anesthetics" class="nav-link" data-scroll-target="#anesthetics">Anesthetics</a></li>
  <li><a href="#corticosteroids" id="toc-corticosteroids" class="nav-link" data-scroll-target="#corticosteroids">Corticosteroids</a></li>
  <li><a href="#propylene-glycol" id="toc-propylene-glycol" class="nav-link" data-scroll-target="#propylene-glycol">Propylene Glycol</a></li>
  <li><a href="#eye-drops" id="toc-eye-drops" class="nav-link" data-scroll-target="#eye-drops">Eye Drops</a></li>
  </ul></li>
  <li><a href="#vaccines" id="toc-vaccines" class="nav-link" data-scroll-target="#vaccines">Vaccines</a>
  <ul>
  <li><a href="#background-6" id="toc-background-6" class="nav-link" data-scroll-target="#background-6">Background</a></li>
  <li><a href="#skin-testing-4" id="toc-skin-testing-4" class="nav-link" data-scroll-target="#skin-testing-4">Skin Testing</a></li>
  <li><a href="#management-3" id="toc-management-3" class="nav-link" data-scroll-target="#management-3">Management</a></li>
  </ul></li>
  </ul>
<div class="toc-actions"><ul><li><a href="https://github.com/mattkrantz/tb4i/edit/main/specific-drugs.qmd" class="toc-action"><i class="bi bi-github"></i>Edit this page</a></li><li><a href="https://github.com/mattkrantz/tb4i/issues/new" class="toc-action"><i class="bi empty"></i>Report an issue</a></li></ul></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default"><nav class="quarto-page-breadcrumbs quarto-title-breadcrumbs d-none d-lg-block" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./drug-allergy.html">Drug Allergy</a></li><li class="breadcrumb-item"><a href="./specific-drugs.html"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Specific Drugs</span></a></li></ol></nav>
<div class="quarto-title">
<h1 class="title"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Specific Drugs</span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<section id="antibiotics" class="level2">
<h2 class="anchored" data-anchor-id="antibiotics">Antibiotics</h2>
<section id="cephalosporins" class="level3">
<h3 class="anchored" data-anchor-id="cephalosporins">Cephalosporins</h3>
</section>
<section id="fluoroquinolones" class="level3">
<h3 class="anchored" data-anchor-id="fluoroquinolones">Fluoroquinolones</h3>
</section>
<section id="macrolides" class="level3">
<h3 class="anchored" data-anchor-id="macrolides">Macrolides</h3>
<section id="background" class="level4">
<h4 class="anchored" data-anchor-id="background">Background</h4>
<div id="macrolides-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-1-contents" aria-controls="callout-1" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the chemical structure of macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-1" class="callout-1-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Macrolides are defined by a large lactone ring, which varies from 12 to 16 carbons, with 1 or more attached sugar chains. Eyrthromycin and clarithromycin have 14 carbons in their lactone rings while azithromycin has 15.</p>
</div>
</div>
</div>
<div id="macrolides-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-2-contents" aria-controls="callout-2" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the mechanism of action of macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-2" class="callout-2-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>As 50S ribosomal subunit inhibitors, macrolides exert their bacteriostatic effect by inhibiting protein synthesis.</p>
</div>
</div>
</div>
<div id="macrolides-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-3-contents" aria-controls="callout-3" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the cross-reactivity pattern macrolide antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-3" class="callout-3-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>While not extensively studied, macrolide antibiotics with a different number of carbon atoms in their lactone ring are tolerated by most patients. Macrolide antibiotics are also unlikely to cross-react with macrolide immunosuppressants (e.g., tacrolimus, sirolimus).</p>
</div>
</div>
</div>
<div id="macrolides-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-4-contents" aria-controls="callout-4" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some infections that use macrolides as first-line therapy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-4" class="callout-4-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Clarithyromycin is used as part of combination treatment for H. pylori. Azithromycin is a part of the first-line combination therapy for Mycobacterium avium complex.</p>
</div>
</div>
</div>
<div id="macrolides-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-5-contents" aria-controls="callout-5" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What non-hypersensitivity reactions are associated with macrolides?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-5" class="callout-5-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ol type="1">
<li><p>GI side effects: Because macrolides are also agonists for the motilin receptor–stimulating gastric and small intestine motility–they can cause nausea, vomiting, diarrhea, and abdmoninal cramping. Accordingly, erythromycin can be used as a treatment for gastroparesis.</p></li>
<li><p>Sensorineural ototoxicity (usually transient).</p></li>
<li><p>QT interval prolongation.</p></li>
</ol>
</div>
</div>
</div>
</section>
<section id="skin-testing" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing">Skin Testing</h4>
<p>Skin testing for macrolide immediate hypersensitivity has not been shown to be reliable.</p>
</section>
<section id="oral-challenge" class="level4">
<h4 class="anchored" data-anchor-id="oral-challenge">Oral Challenge</h4>
<p>For patients with a history of immediate hypersensitivity reaction to a macrolide, graded azithromycin challenge can be performed, starting with azithromycin 25 mg followed by 1 hour observation then 250 mg followed by 2 hour observation.</p>
<p>For patients with a history of non-severe delayed hypersensitivity reaction to a macrolide, single dose azithromycin 250 mg challenge with 2 hour observation can be performed. Patients should be instructed to report any other delayed symptoms, which may occur up to 24 to 48 hours after the challenge dose.</p>
</section>
</section>
<section id="penicillins" class="level3">
<h3 class="anchored" data-anchor-id="penicillins">Penicillins</h3>
<section id="background-1" class="level4">
<h4 class="anchored" data-anchor-id="background-1">Background</h4>
<div id="penicillins-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-6-contents" aria-controls="callout-6" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of the US population reports an allergy to penicillin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-6" class="callout-6-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Approximately 10% of the US population reports an allergy to penicillin.</p>
</div>
</div>
</div>
<div id="penicillins-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-7-contents" aria-controls="callout-7" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Of individuals reporting a penicillin allergy, what percent are clinically significant immediate or delayed immune-mediated drug reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-7" class="callout-7-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Less than 5% of these reported penicillin allergies are clinically significant immediate or delayed-immune mediated drug reactions.</p>
<p>Over 95% of patients who do not have a history of serious penicillin allergy are actually tolerant because (1) the most common reported reaction is a benign delayed rash (type IV hypersensitivity reaction) which may or may not recur with subsequent penicillin exposure; (2) IgE-mediated penicillin allergy wanes over time, with 80% of patients becoming tolerant after a decade since their index reaction; and (3) the index reaction may have rather been an intolerance or caused by the underlying infection being treated at the time.</p>
</div>
</div>
</div>
<div id="penicillins-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-8-contents" aria-controls="callout-8" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What infections are individuals with a history of penicillin allergy at higher risk of developing due to receiving broad-spectrum antibiotics?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-8" class="callout-8-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Individuals who report a penicillin allergy label are more likely to receive broad-spectrum antibiotics that increase the risk for antimicrobial resistance, including methicillin-resistant <em>Staphylococcus aureus</em> and vancomycin-resistant <em>Enterococcus</em>. In addition, broad-spectrum antibiotics also increase the risk of developing <em>Clostridium difficile</em> infection.</p>
<p>Receipt of non-beta-lactam perioperative prophylaxis has been associated with an increased risk of surgical site infections.</p>
</div>
</div>
</div>
<div id="penicillins-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-9-contents" aria-controls="callout-9" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What infection-related drug interaction is associated with individuals developing a maculopapular rash when receiving an aminopenicillin?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-9" class="callout-9-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Epstein-Barr virus</p>
</div>
</div>
</div>
<div id="penicillins-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-10-contents" aria-controls="callout-10" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What percent of penicillin administrations result in a reaction that could be consistent with a hypersensitivity reaction, most often a rash, that could also be nonallergic?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-10" class="callout-10-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>About 0.5% to 2.0%</p>
</div>
</div>
</div>
<div id="penicillins-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-11-contents" aria-controls="callout-11" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Currently the rate of IgE-mediated penicillin allergies is decreasing. What is a potential hypothesis for this trend?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-11" class="callout-11-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Potentially due to the decrease in use of parenteral penicillins in the outpatient setting, where most antibiotic use occurs.</p>
<div class="cell">
<div class="cell-output-display">
<div class="plotly html-widget html-fill-item" id="htmlwidget-f616074cc843807f436b" style="width:100%;height:464px;"></div>
<script type="application/json" data-for="htmlwidget-f616074cc843807f436b">{"x":{"data":[{"x":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"y":[15.4,9.1999999999999993,8,9.5999999999999996,4.0999999999999996,8.6999999999999993,10.800000000000001,8.8000000000000007,4.7000000000000002,4.7999999999999998,4.5,4.0999999999999996,3.3999999999999999],"text":["Year: 1995<br />Percent_Positive: 15.4","Year: 1996<br />Percent_Positive:  9.2","Year: 1997<br />Percent_Positive:  8.0","Year: 1998<br />Percent_Positive:  9.6","Year: 1999<br />Percent_Positive:  4.1","Year: 2000<br />Percent_Positive:  8.7","Year: 2001<br />Percent_Positive: 10.8","Year: 2002<br />Percent_Positive:  8.8","Year: 2003<br />Percent_Positive:  4.7","Year: 2004<br />Percent_Positive:  4.8","Year: 2005<br />Percent_Positive:  4.5","Year: 2006<br />Percent_Positive:  4.1","Year: 2007<br />Percent_Positive:  3.4"],"type":"scatter","mode":"lines+markers","line":{"width":1.8897637795275593,"color":"rgba(0,0,0,1)","dash":"solid"},"hoveron":"points","showlegend":false,"xaxis":"x","yaxis":"y","hoverinfo":"text","marker":{"autocolorscale":false,"color":"rgba(0,0,0,1)","opacity":1,"size":5.6692913385826778,"symbol":"circle","line":{"width":1.8897637795275593,"color":"rgba(0,0,0,1)"}},"frame":null}],"layout":{"margin":{"t":43.762557077625573,"r":7.3059360730593621,"b":40.182648401826498,"l":37.260273972602747},"font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724},"title":{"text":"Percentage of Positive Cases Over Time","font":{"color":"rgba(0,0,0,1)","family":"","size":17.534246575342465},"x":0,"xref":"paper"},"xaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[1994.4000000000001,2007.5999999999999],"tickmode":"array","ticktext":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"tickvals":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"categoryorder":"array","categoryarray":[1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.6529680365296811,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"","size":11.68949771689498},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176002,"zeroline":false,"anchor":"y","title":{"text":"Year","font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724}},"hoverformat":".2f"},"yaxis":{"domain":[0,1],"automargin":true,"type":"linear","autorange":false,"range":[2.7999999999999998,16],"tickmode":"array","ticktext":["3","6","9","12","15"],"tickvals":[3,6,9,12,15],"categoryorder":"array","categoryarray":["3","6","9","12","15"],"nticks":null,"ticks":"","tickcolor":null,"ticklen":3.6529680365296811,"tickwidth":0,"showticklabels":true,"tickfont":{"color":"rgba(77,77,77,1)","family":"","size":11.68949771689498},"tickangle":-0,"showline":false,"linecolor":null,"linewidth":0,"showgrid":true,"gridcolor":"rgba(235,235,235,1)","gridwidth":0.66417600664176002,"zeroline":false,"anchor":"x","title":{"text":"Percent Positive (%)","font":{"color":"rgba(0,0,0,1)","family":"","size":14.611872146118724}},"hoverformat":".2f"},"shapes":[{"type":"rect","fillcolor":null,"line":{"color":null,"width":0,"linetype":[]},"yref":"paper","xref":"paper","x0":0,"x1":1,"y0":0,"y1":1}],"showlegend":false,"legend":{"bgcolor":null,"bordercolor":null,"borderwidth":0,"font":{"color":"rgba(0,0,0,1)","family":"","size":11.68949771689498}},"hovermode":"closest","barmode":"relative"},"config":{"doubleClick":"reset","modeBarButtonsToAdd":["hoverclosest","hovercompare"],"showSendToCloud":false},"source":"A","attrs":{"38a868319e17":{"x":{},"y":{},"type":"scatter"},"38a811822d72":{"x":{},"y":{}}},"cur_data":"38a868319e17","visdat":{"38a868319e17":["function (y) ","x"],"38a811822d72":["function (y) ","x"]},"highlight":{"on":"plotly_click","persistent":false,"dynamic":false,"selectize":false,"opacityDim":0.20000000000000001,"selected":{"opacity":1},"debounce":0},"shinyEvents":["plotly_hover","plotly_click","plotly_selected","plotly_relayout","plotly_brushed","plotly_brushing","plotly_clickannotation","plotly_doubleclick","plotly_deselect","plotly_afterplot","plotly_sunburstclick"],"base_url":"https://plot.ly"},"evals":[],"jsHooks":[]}</script>
</div>
</div>
</div>
</div>
</div>
</section>
<section id="skin-testing-1" class="level4">
<h4 class="anchored" data-anchor-id="skin-testing-1">Skin Testing</h4>
<div id="penicillins-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-12-contents" aria-controls="callout-12" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the NPV of penicillin skin testing?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-12" class="callout-12-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The NPV of penicillin skin testing is &gt; 95% when performed with only PPL plus penicillin G or with PPL plus full panel of minor derterminants.</p>
</div>
</div>
</div>
<table class="caption-top table">
<colgroup>
<col style="width: 13%">
<col style="width: 82%">
<col style="width: 3%">
</colgroup>
<thead>
<tr class="header">
<th>Reagent</th>
<th>Description</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Penicilloyl polylysine (PPL, PrePen®)</td>
<td><ul>
<li>Major antigenic determinant (what 95% of penicillin degrades into); PPL is penicilloyl complexed with polyltysine to constitute a multivalent skin test reagent. Polylysine acts like the carrier for the penicilloyl hapten in vivo.</li>
</ul></td>
<td></td>
</tr>
<tr class="even">
<td>Minor derterminant mixture (MDM)</td>
<td><ul>
<li>Penicillin itself, penicilloate, penilloate | |</li>
<li>Not commercially available expect in South America and Spain</li>
</ul></td>
<td></td>
</tr>
<tr class="odd">
<td>Penicillin G</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>Ampicillin</td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>Selective IgE-mediated reactions to aminopenicillins are rare in North America (e.g.&nbsp;3-5% in the United States) versus 25-50% of skin test positive patients in Europe.</p>
</div>
</div>
<p><strong>References:</strong></p>
<p>Chapter 77 Middleton’s Drug Allergy</p>
</section>
</section>
<section id="sulfa-antibiotics" class="level3">
<h3 class="anchored" data-anchor-id="sulfa-antibiotics">Sulfa Antibiotics</h3>
</section>
<section id="vancomycin" class="level3">
<h3 class="anchored" data-anchor-id="vancomycin">Vancomycin</h3>
</section>
</section>
<section id="antiepileptic-drugs" class="level2">
<h2 class="anchored" data-anchor-id="antiepileptic-drugs">Antiepileptic Drugs</h2>
<section id="background-2" class="level3">
<h3 class="anchored" data-anchor-id="background-2">Background</h3>
<div id="antiepileptic-drugs-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-14-contents" aria-controls="callout-14" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
How are antiepileptic drugs (AEDs) broadly categorized?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-14" class="callout-14-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>AEDs can be broadly categorized by their structure: aromatic or non-aromatic.</p>
</div>
</div>
</div>
<div id="antiepileptic-drugs-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-15-contents" aria-controls="callout-15" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What defines an “aromatic” versus a “non-aromatic” AED?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-15" class="callout-15-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Historically, compounds were labeled as aromatic based on their distinctive aromas.</p>
<p>Today, <a href="https://en.wikipedia.org/wiki/Aromatic_compound">aromatic compounds</a> and AEDs are defined by containing a benzene ring or other benzene-like properties.</p>
<p><a href="https://en.wikipedia.org/wiki/Benzene">Benzene</a> has a sweet odor and is found naturally (e.g., crude oil) and produced as an intermediate for use in plastics, resins, nylons, synthetic fibers.</p>
<div id="fig-benzene" class="quarto-figure quarto-figure-center quarto-float anchored" data-fig-align="center">
<figure class="quarto-float quarto-float-fig figure">
<div aria-describedby="fig-benzene-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<img src="images/specific-drugs/fig-benzene.png" class="img-fluid quarto-figure quarto-figure-center figure-img" width="119">
</div>
<figcaption class="quarto-float-caption-bottom quarto-float-caption quarto-float-fig" id="fig-benzene-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Figure&nbsp;7.1: 2D skeletal representation of benzene
</figcaption>
</figure>
</div>
</div>
</div>
</div>
<div id="antiepileptic-drugs-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-16-contents" aria-controls="callout-16" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Which class of AEDs are associated with the greatest risk of rash and other cutaneous ADRs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-16" class="callout-16-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Aromatic AEDs are associated with the greatest occurence of rash and other cutaneous ADRs, including phenytoin, carbamazepine, phenobarbital, lamotrigine, zonisamide, and oxcarbazapine.</p>
<p>In addition, there is greater cross-reactivity amongst aromatic AEDs (40-58%) than non-aromatic AEDs.</p>
<p>Of the AEDs with lower rash risk, most are non-aromatic (e.g.&nbsp;valproate, gabapentin, levetiracetam, pregabalin, vigabatrin, lacosamide, brivaracetam).</p>
</div>
</div>
</div>
<div id="tbl-aeds" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-aeds-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;7.1: Select aromatic and non-aromatic AEDs. Adapted from Mani et al.&nbsp;Seizure. 2019.
</figcaption>
<div aria-describedby="tbl-aeds-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 30%">
<col style="width: 27%">
</colgroup>
<thead>
<tr class="header">
<th>Aromatic AEDs</th>
<th>Non-aromatic AEDs</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><ul>
<li><p>Ethosuximide</p></li>
<li><p>Phenytoin</p></li>
<li><p>Phenobarbital</p></li>
<li><p>Carbamepine</p></li>
<li><p>Oxcarbazepine</p></li>
<li><p>Zonisamide</p></li>
<li><p>Lamotrigine</p></li>
<li><p>Clobazam</p></li>
<li><p>Felbamate</p></li>
<li><p>Primidone</p></li>
<li><p>Eslicarbazepine</p></li>
<li><p>Perampanel</p></li>
<li><p>Cannabidiol</p></li>
</ul></td>
<td><ul>
<li><p>Valproate</p></li>
<li><p>Gabapentin</p></li>
<li><p>Topiramate</p></li>
<li><p>Levetiracetam</p></li>
<li><p>Pregabalin</p></li>
<li><p>Vigabatrin</p></li>
<li><p>Lacosamide</p></li>
<li><p>Brivaracetam</p></li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<div id="antiepileptic-drugs-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-17-contents" aria-controls="callout-17" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some risk factors for developing AED-induced rashes?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-17" class="callout-17-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ul>
<li><p>History of previous AED-related skin reaction</p></li>
<li><p>Female &gt; Male (2:1), though difference does not persist after &gt; age 50 years</p></li>
<li><p>Older age</p></li>
<li><p>Low vitamin D concentrations</p></li>
</ul>
</div>
</div>
</div>
<p><strong>Reference</strong></p>
<p>Mani R, Monteleone C, Schalock PC, Truong T, Zhang XB, Wagner ML. Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature. Seizure. 2019 Oct;71:270-278. doi: 10.1016/j.seizure.2019.07.015. Epub 2019 Jul 24. PMID: 31491658.</p>
</section>
</section>
<section id="buproprion" class="level2">
<h2 class="anchored" data-anchor-id="buproprion">Buproprion</h2>
</section>
<section id="iron" class="level2">
<h2 class="anchored" data-anchor-id="iron">Iron</h2>
<section id="background-3" class="level3">
<h3 class="anchored" data-anchor-id="background-3">Background</h3>
<div id="iron-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-18-contents" aria-controls="callout-18" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Why is intravenous (IV) iron used?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-18" class="callout-18-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>IV iron is used for the treatment of iron deficiency anemia when oral iron is effective or not tolerated.</p>
</div>
</div>
</div>
<div id="iron-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-20-contents" aria-controls="callout-20" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What IV iron formulations are available in the United States?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-20" class="callout-20-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Formulations available in the United States include low-molecular-weight iron dextran (LWMID), ferric gluconate, iron sucrose, ferumoxytol, iron isomaltoside, and ferric carboxymaltose.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>High-molecular weight iron dextrans were discontinued in the United States due to having a higher rate of hypersensitivity reactions.</p>
</div>
</div>
</div>
</div>
</div>
<div id="tbl-iv-iron" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-iv-iron-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;7.2: Characteristics of iron formulations available in the United States
</figcaption>
<div aria-describedby="tbl-iv-iron-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 23%">
<col style="width: 12%">
<col style="width: 11%">
<col style="width: 6%">
<col style="width: 17%">
<col style="width: 14%">
<col style="width: 10%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">Generic name</th>
<th style="text-align: center;">Iron gluconate</th>
<th style="text-align: center;">Iron Sucrose</th>
<th style="text-align: center;">LMWID</th>
<th style="text-align: center;">Ferric carboxymaltose</th>
<th style="text-align: center;">Iron isomaltoside</th>
<th style="text-align: center;">Ferumoxytol</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">Brand name</td>
<td style="text-align: center;">Ferrlecit</td>
<td style="text-align: center;">Venofer</td>
<td style="text-align: center;">INFeD</td>
<td style="text-align: center;">Injectafer</td>
<td style="text-align: center;">Monofer</td>
<td style="text-align: center;">FeraHeme</td>
</tr>
<tr class="even">
<td style="text-align: center;">Molecular weight (kD)</td>
<td style="text-align: center;">289-440</td>
<td style="text-align: center;">30-60</td>
<td style="text-align: center;">165</td>
<td style="text-align: center;">150</td>
<td style="text-align: center;">150</td>
<td style="text-align: center;">750</td>
</tr>
<tr class="odd">
<td style="text-align: center;">Labile iron (% injected dose)</td>
<td style="text-align: center;">3.3</td>
<td style="text-align: center;">3.5</td>
<td style="text-align: center;">2</td>
<td style="text-align: center;">0.6</td>
<td style="text-align: center;">1</td>
<td style="text-align: center;">0.8</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
</section>
<section id="immediate-hypersensitivity-reactions" class="level3">
<h3 class="anchored" data-anchor-id="immediate-hypersensitivity-reactions">Immediate Hypersensitivity Reactions</h3>
<div id="iron-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-21-contents" aria-controls="callout-21" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the incidence of anaphylactic reactions with IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-21" class="callout-21-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Anaphylactic reactions—when high-molecular weight dextrans are excluded—occur with an incidence of &lt; 1 in 200,000.</p>
<p>Significant differences in reaction risk have not been shown among low-molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxymaltose.</p>
</div>
</div>
</div>
<div id="iron-question-4" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-22-contents" aria-controls="callout-22" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the mechanism of most IV iron immediate hypersensitivity reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-22" class="callout-22-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Most IV iron immediate hypersensitivity reactions are mediated through complement-activation related pseudoallergy (CARPA). Rarely, hypersensitivity reactions are IgE-mediated.</p>
</div>
</div>
</div>
</section>
<section id="minor-infusion-reactions" class="level3">
<h3 class="anchored" data-anchor-id="minor-infusion-reactions">Minor Infusion Reactions</h3>
<div id="iron-question-5" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-23-contents" aria-controls="callout-23" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are the symptoms of minor infusion reactions to IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-23" class="callout-23-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Symptoms of minor infusion reactions to IV iron include—flushing, chest/back tightness, myalgias—and, importantly, do not have any features of anaphylaxis.</p>
</div>
</div>
</div>
<div id="iron-question-6" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-24-contents" aria-controls="callout-24" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is considered to be the main driver of minor infusion reactions to IV iron?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-24" class="callout-24-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Labile, or also called “free,” iron is associated with minor infusion reactions to IV iron.</p>
</div>
</div>
</div>
</section>
<section id="skin-testing-2" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-2">Skin Testing</h3>
<div id="iron-question-7" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-25-contents" aria-controls="callout-25" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the utility of immediate skin testing for IV iron hypersensitivity reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-25" class="callout-25-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>As most hypersensitivity reactions are non-IgE-mediated—rather via CARPA—skin testing has limited utility for evaluating IV iron hypersensitivity reactions; however, it may help detect the rare patients with IgE-mediated hypersensitivity.</p>
</div>
</div>
</div>
</section>
<section id="management" class="level3">
<h3 class="anchored" data-anchor-id="management">Management</h3>
<div id="iron-question-8" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-26-contents" aria-controls="callout-26" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are some approaches to subsequent IV iron administration in patients with previous IV iron reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-26" class="callout-26-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Approaches for patients with history of mild to moderate IV iron reactions include: switching to an alternative IV iron formulation, slowing the infusion rate (e.g., 10% of recommended rate during the first 10 to 15 minutes), and/or pre-treatment with non-sedating, second generation antihistamines.</p>
<p>For patients with a history of anaphylactic reactions to IV iron, desensitization can be considered, such as ferric gluconate.</p>
</div>
</div>
</div>
</section>
<section id="references" class="level3">
<h3 class="anchored" data-anchor-id="references">References</h3>
<p>Gómez-Ramírez S, Shander A, Spahn DR, et al.&nbsp;Prevention and management of acute reactions to intravenous iron in surgical patients. <em>Blood Transfusion</em>. Published online April 10, 2019. doi:<a href="https://doi.org/10.2450/2018.0156-18">10.2450/2018.0156-18</a></p>
<p>Muñoz M, Gómez-Ramírez S, Bhandari S. The safety of available treatment options for iron-deficiency anemia. Expert Opin Drug Saf 2018; 17: 149-59.</p>
</section>
</section>
<section id="local-anesthetics" class="level2">
<h2 class="anchored" data-anchor-id="local-anesthetics">Local Anesthetics</h2>
</section>
<section id="nonsteroidal-anti-inflammatory-drugs" class="level2">
<h2 class="anchored" data-anchor-id="nonsteroidal-anti-inflammatory-drugs">Nonsteroidal Anti-Inflammatory Drugs</h2>
<section id="background-4" class="level3">
<h3 class="anchored" data-anchor-id="background-4">Background</h3>
<div id="nsaids-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-27-contents" aria-controls="callout-27" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the prevalence of nonsteroidal anti-inflammatory drug (NSAID) allergy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-27" class="callout-27-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>In the general population, 1.5 - 3.5% of individuals report an NSAID allergy. However, fewer than 20% of those individuals with self-reported NSAID allergy are consistent with a true hypersensitivity.</p>
</div>
</div>
</div>
<div id="nsaids-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-28-contents" aria-controls="callout-28" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
WWhat are some important therapeutic uses of NSAIDs?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-28" class="callout-28-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>NSAIDs are important for the treatment of acute coronary syndrome, pain treatment, and for certain high-risk pregnancy conditions.</p>
<p>For individuals with chronic back pain, NSAID allergy is a risk factor for increased receipt of opioid prescriptions and development of opioid use disorder.</p>
</div>
</div>
</div>
</section>
<section id="management-1" class="level3">
<h3 class="anchored" data-anchor-id="management-1">Management</h3>
<p>For non-aspirin exacerbated respiratory disease (AERD) NSAID hypersensitivity, a two-step outpatient NSAID oral challenge has been shown to be a safe and effective approach.</p>
<div id="nsaids-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-29-contents" aria-controls="callout-29" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What factors are associated with a positive NSAID challenge?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-29" class="callout-29-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<ul>
<li><p>NSAID reaction within the past 5 years</p></li>
<li><p>Prior immediate reaction within 3 hours of NSAID ingestion</p></li>
<li><p>History of reaction to multiple NSAIDs</p></li>
<li><p>Presence of co-morbid chronic spontaneous urticaria</p></li>
</ul>
</div>
</div>
</div>
</section>
<section id="oral-challenge-1" class="level3">
<h3 class="anchored" data-anchor-id="oral-challenge-1">Oral Challenge</h3>
<div id="tbl-nsaids" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-nsaids-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;7.3: Proposed two-step protocol for outpatient NSAID oral challenge in patients without AERD. Adapted from Li et al.&nbsp;JACI In Practice. 2022
</figcaption>
<div aria-describedby="tbl-nsaids-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 23%">
<col style="width: 36%">
<col style="width: 37%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">NSAID</th>
<th style="text-align: center;"><p>Step 1 Dose</p>
<p>(60 minute observation)</p></th>
<th style="text-align: center;"><p>Step 2 Dose</p>
<p>(120 minute observation)</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">Aspirin</td>
<td style="text-align: center;">40.5 mg</td>
<td style="text-align: center;">325 mg</td>
</tr>
<tr class="even">
<td style="text-align: center;">Ibuprofen</td>
<td style="text-align: center;">50 mg</td>
<td style="text-align: center;">500 mg</td>
</tr>
<tr class="odd">
<td style="text-align: center;">Naproxen</td>
<td style="text-align: center;">60 mg</td>
<td style="text-align: center;">600 mg</td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>Because of the potential future need for higher dose of aspirin for management of acute coronary syndrome, the second dose for aspirin oral challenge is 325 mg instead of 81 mg.</p>
<p>Of the 262 NSAID challenges performed in the Li et al study, over 85% had negative challenges. In addition, 76% of patients included in the study reported a history of urticaria, angioedema, or both. For patients experiencing a positive challenge, 45% had their reaction within 3 hours of NSAID ingestion</p>
<p><strong>Reference</strong></p>
<p>Li L, Bensko J, Buchheit K, Saff RR, Laidlaw TM. Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges. J Allergy Clin Immunol Pract. 2022 May;10(5):1286-1292.e2. doi: 10.1016/j.jaip.2021.11.006. Epub 2021 Nov 17. PMID: 34800703; PMCID: PMC9086081.</p>
</section>
</section>
<section id="radiocontrast" class="level2">
<h2 class="anchored" data-anchor-id="radiocontrast">Radiocontrast</h2>
<section id="background-5" class="level3">
<h3 class="anchored" data-anchor-id="background-5">Background</h3>
<div id="radiocontrast-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-30-contents" aria-controls="callout-30" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
How do modern radiocontrasts differ from older radiocontrasts?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-30" class="callout-30-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>Modern radiocontrasts are non-ionic, iodinated and either iso-osmolal or low-osmolality. Older radiocontrasts were high-osmolality–which are no longer used intravenously.</p>
</div>
</div>
</div>
<div id="radiocontrast-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-31-contents" aria-controls="callout-31" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Is radiocontrast allergy related to iodine or seafood allergy?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-31" class="callout-31-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The radiocontrast molecular structure is responsible for hypersensitivity reactions–not iodine or seafood allergy. Shellfish allergy is secondary to tropomyosin not iodine.</p>
</div>
</div>
</div>
</section>
<section id="infusion-reactions" class="level3">
<h3 class="anchored" data-anchor-id="infusion-reactions">Infusion Reactions</h3>
<p>These are also referred to as “toxic” or “chemotoxic” reactions. Characteristic symptoms include transient warmth/flushing, nausea/vomiting, chest pain, metallic taste, hypertension, and/or vasogal signs.</p>
</section>
<section id="immediate-hypersensitivity-reactions-1" class="level3">
<h3 class="anchored" data-anchor-id="immediate-hypersensitivity-reactions-1">Immediate Hypersensitivity Reactions</h3>
<p>The most common immediate hypersensitivity reaction to radiocontrast is mild urticaria and pruritus, occuring in ~0.9% - 3.1% of patients receiving radiocontrast. Anaphylaxis occurs in 0.02% - 0.04% of patients. Of immediate hypersensitivity reactions, 70% occur within 5 minutes of radiocontrast injection and 96% of severe reactions occur within 20 minutes.</p>
</section>
<section id="delayed-hypersensitivity-reactions" class="level3">
<h3 class="anchored" data-anchor-id="delayed-hypersensitivity-reactions">Delayed Hypersensitivity Reactions</h3>
<p>The most common delayed hypersensitivity reaction to radiocontrast is a maculopapular exanthem–occurring in 1 to 3% of patients.</p>
</section>
<section id="skin-testing-3" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-3">Skin Testing</h3>
<p>Skin prick testing to the culprit and other radiocontrasts followed by intradermal testing–if skin prick testing is negative–can be useful for identifying an alternative radiocontrast agent. A skin test negative radiocontrast alternative has a 95% NPV.</p>
</section>
<section id="intravenous-challenge" class="level3">
<h3 class="anchored" data-anchor-id="intravenous-challenge">Intravenous Challenge</h3>
<p>Intravenous challenge can be performed to radiocontrast with various protocols–such as 1 mL, 5 mL, 15, mL, and 50 mL (cumulative 71 mL) at 60 minute intervals.</p>
</section>
<section id="management-2" class="level3">
<h3 class="anchored" data-anchor-id="management-2">Management</h3>
<p>The culprit radiocontrast should be avoided, and an alternative radiocontrast should be used, guided by negative skin testing if available. Other measures to decrease risk of recurrent radiocontrast reaction include: lowering the radiocontrast dose, decreasing the injection speed, and pre-treatment with non-sedating, second generation antihistamines and/or corticosteroids.</p>
</section>
</section>
<section id="topicals" class="level2">
<h2 class="anchored" data-anchor-id="topicals">Topicals</h2>
<section id="antibiotics-1" class="level3">
<h3 class="anchored" data-anchor-id="antibiotics-1">Antibiotics</h3>
<p>The most common topical antibiotics which cause ACD are those found in triple antibiotic ointment—neomycin, polymyxin B, and bacitracin.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>Of patients with neomycin ACD, 50% will cross-react with other aminoglycosides such as gentamicin.</p>
</div>
</div>
</section>
<section id="anesthetics" class="level3">
<h3 class="anchored" data-anchor-id="anesthetics">Anesthetics</h3>
<p>The most common topical anesthetics which cause ACD are lidocaine and benzocaine.</p>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>While patch testing can confirm ACD due to a local anesthetic, not all patients will necessarily develop an allergic reaction to the same anesthetic if used intradermally or subcutaneous—which is often done for dental and dermatologic procedures.</p>
</div>
</div>
</section>
<section id="corticosteroids" class="level3">
<h3 class="anchored" data-anchor-id="corticosteroids">Corticosteroids</h3>
<p>Most patients with ACD secondary to corticosteroids have a history of atopy. Because corticosteroids are often not considered initially as a possible cause of ACD, there might be increased use and worsening of a patient’s dermatitis.</p>
<p>ACD due to corticosteroids may produce an “edge effect” or “doughnut-type” reaction–due to the anti-inflammatory effect of the higher concentration of the corticosteroid in the central area compared to the periphery.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>If a patient has ACD due to a topical corticosteroid, you should consider propylene glycol as a potential cause—an excipient found in various topical corticosteroids and one of the top 4 causes of ACD due to drugs.</p>
</div>
</div>
</section>
<section id="propylene-glycol" class="level3">
<h3 class="anchored" data-anchor-id="propylene-glycol">Propylene Glycol</h3>
<p>Propylene glycol—an excipient—may be utilized in topical drugs as a softening agent, solvent, moisturizer, or preservative.</p>
<p>Of patients with propylene glycol ACD, 80% have a history of atopic dermatitis.</p>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Important
</div>
</div>
<div class="callout-body-container callout-body">
<p>Propylene glycol is present in various topical emolients, corticosteroids, and calcineurin inhibitors.</p>
</div>
</div>
<div id="tbl-topicals-propylene-glycol" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-topicals-propylene-glycol-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;7.4: Select topical drugs for treatment of atopic dermatitis by propylene glcyol content
</figcaption>
<div aria-describedby="tbl-topicals-propylene-glycol-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<thead>
<tr class="header">
<th>Topical</th>
<th>Propylene glycol-containing</th>
<th>Propylene glycol-free</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Emolients</td>
<td><ul>
<li><a href="https://www.cetaphil.com/us/moisturizers/moisturizing-cream/302993917564.html#productIngredients">Cetaphil Moisturizing Cream</a></li>
</ul></td>
<td><ul>
<li><p><a href="https://www.cerave.com/skincare/moisturizers/moisturizing-cream#product-description">Cerave Moisturizing Cream</a></p></li>
<li><p><a href="https://www.eucerinus.com/products/original/eucerin-original-healing-soothing-repair-creme">Eucerin Orginal Healing Cream</a></p></li>
</ul></td>
</tr>
<tr class="even">
<td>Corticosteroids</td>
<td><ul>
<li>Mometasone furoate ointment 0.1%</li>
</ul></td>
<td><ul>
<li><p>Triamcinolone acetonide ointment 0.1%</p></li>
<li><p>Hydrocortisone ointment 2.5%</p></li>
</ul></td>
</tr>
<tr class="odd">
<td>Calcineurin inhibitors</td>
<td><ul>
<li>Pimecrolimus cream 1%</li>
</ul></td>
<td><ul>
<li>Tacrolimus ointment 0.03% and 0.1%</li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>References:</p>
<p><a href="https://www.jaad.org/article/S0190-9622(19)33110-X/fulltext" class="uri">https://www.jaad.org/article/S0190-9622(19)33110-X/fulltext</a></p>
</section>
<section id="eye-drops" class="level3">
<h3 class="anchored" data-anchor-id="eye-drops">Eye Drops</h3>
<p>The eyelids are more susceptible to ACD compared to other facial areas—owing to their thin skin 0.55 mm compared to 2 mm, respectively. Therefore, the eyelids may be the only affected area by a drug that comes in contact with the face.</p>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Note
</div>
</div>
<div class="callout-body-container callout-body">
<p>ACD due to eye drops is primarily caused by anti-microbial preservatives rather than the primary drug. Benzylalkonium chloride is the most commonly implicated preservative in patients with history of eye drop reactions.</p>
</div>
</div>
<div id="tbl-eyedrops-benzalkonium-chloride" class="quarto-float anchored">
<figure class="quarto-float quarto-float-tbl figure">
<figcaption class="quarto-float-caption-top quarto-float-caption quarto-float-tbl" id="tbl-eyedrops-benzalkonium-chloride-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
Table&nbsp;7.5: Select commercially-available eye drops for common treatment categories by benzylalkonium chloride content
</figcaption>
<div aria-describedby="tbl-eyedrops-benzalkonium-chloride-caption-0ceaefa1-69ba-4598-a22c-09a6ac19f8ca">
<table class="caption-top table">
<colgroup>
<col style="width: 14%">
<col style="width: 51%">
<col style="width: 33%">
</colgroup>
<thead>
<tr class="header">
<th>Category</th>
<th>Benzyalkonium chloride-containing</th>
<th>Benyzlalkonium chloride-free</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Antibiotic</td>
<td><ul>
<li><p>Ciprofloxacin (Ciloxan)</p></li>
<li><p>Gatifloxacin (Zymar)</p></li>
<li><p>Neomycin/Polymyxin B sulfates/Dexamethasone (Maxitrol)</p></li>
<li><p>Ofloxacin (Ocuflox)</p></li>
<li><p>Polymyxin B sulfate/Trimethoprim (Polytrim)</p></li>
<li><p>Tobramycin (Tobrex)</p></li>
</ul></td>
<td><ul>
<li><p>Moxifloxacin (Vigamox)</p></li>
<li><p>Erythromycin ointment (Ilotycin)</p></li>
</ul></td>
</tr>
<tr class="even">
<td>Corticosteroid</td>
<td><ul>
<li><p>Dexamethasone (Maxidex)</p></li>
<li><p>Prednisolone acetate</p></li>
<li><p>Prednisolone sodium phosphate</p></li>
</ul></td>
<td><ul>
<li>Loteprednol 0.5% ointment</li>
</ul></td>
</tr>
<tr class="odd">
<td>NSAID</td>
<td><ul>
<li><p>Keterolac 0.4% (Acular LS)</p></li>
<li><p>Ketorolac 0.5% (Acular)</p></li>
</ul></td>
<td><ul>
<li>Keterolac 0.45% (Lotemax)</li>
</ul></td>
</tr>
<tr class="even">
<td>Gluacoma</td>
<td><ul>
<li><p>Brinzolamide (Azopt)</p></li>
<li><p>Timolol (Timoptic)</p></li>
</ul></td>
<td><ul>
<li><p>Tafluprost (Zioptan)</p></li>
<li><p>Latanoprost (Iyuzeh)</p></li>
<li><p>Timolol (Timoptic in Ocudose)</p></li>
<li><p>Dorzolamide/Timolol (Cosopt PF)</p></li>
</ul></td>
</tr>
</tbody>
</table>
</div>
</figure>
</div>
<p>References:</p>
<p><a href="https://eyewiki.org/Preservatives_in_Topical_Ophthalmic_Medications#Benzalkonium_chloride_(BAK)" class="uri">https://eyewiki.org/Preservatives_in_Topical_Ophthalmic_Medications#Benzalkonium_chloride_(BAK)</a></p>
</section>
</section>
<section id="vaccines" class="level2">
<h2 class="anchored" data-anchor-id="vaccines">Vaccines</h2>
<section id="background-6" class="level3">
<h3 class="anchored" data-anchor-id="background-6">Background</h3>
<div id="vaccines-question-1" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-37-contents" aria-controls="callout-37" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the reported incidence of any adverse effect after vaccine administration?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-37" class="callout-37-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>It is estimated that any adverse effect from vaccines occurs in 11.4 per 100,000 administrations.</p>
</div>
</div>
</div>
<div id="vaccines-question-2" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-38-contents" aria-controls="callout-38" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What are the most commonly reported vaccine adverse reactions?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-38" class="callout-38-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The most common vaccine adverse reactions are fever and local injection site reactions–which are not hypersensitivity reactions and are not contraindications to future vaccination.</p>
</div>
</div>
</div>
<div id="vaccines-question-3" class="callout callout-style-simple callout-note no-icon callout-titled">
<div class="callout-header d-flex align-content-center" data-bs-toggle="collapse" data-bs-target=".callout-39-contents" aria-controls="callout-39" aria-expanded="false" aria-label="Toggle callout">
<div class="callout-icon-container">
<i class="callout-icon no-icon"></i>
</div>
<div class="callout-title-container flex-fill">
What is the reported incidence of anaphylaxis to vaccines?
</div>
<div class="callout-btn-toggle d-inline-block border-0 py-1 ps-1 pe-0 float-end"><i class="callout-toggle"></i></div>
</div>
<div id="callout-39" class="callout-39-contents callout-collapse collapse">
<div class="callout-body-container callout-body">
<p>The reported incidence of anaphylaxis is 1.3 case per million doses.</p>
</div>
</div>
</div>
</section>
<section id="skin-testing-4" class="level3">
<h3 class="anchored" data-anchor-id="skin-testing-4">Skin Testing</h3>
</section>
<section id="management-3" class="level3">
<h3 class="anchored" data-anchor-id="management-3">Management</h3>
<table class="caption-top table">
<colgroup>
<col style="width: 58%">
<col style="width: 11%">
<col style="width: 29%">
</colgroup>
<thead>
<tr class="header">
<th>Reaction Type</th>
<th>Perform Skin Testing?</th>
<th>Vaccine Administration by Skin Testing Result (if applicable)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Delayed reaction (e.g.&nbsp;late-onset urticaria, local arm swelling)</td>
<td>No</td>
<td>Subsequent dose in usual manner</td>
</tr>
<tr class="even">
<td>Immediate reaction without IgE-mediated reaction features (e.g.&nbsp;tingling, flushing, palpitation, sensation of throat closure)</td>
<td>No</td>
<td>Subsequent dose in usual manner but observe for 30 minutes</td>
</tr>
<tr class="odd">
<td>Immediate reaction with IgE-mediated reaction features (e.g.&nbsp;urticaria, angioedema, wheezing)</td>
<td>Yes</td>
<td><p>Negative: Usual manner 30 min obs</p>
<p>Positive: Split dose</p></td>
</tr>
<tr class="even">
<td>Anaphylaxis</td>
<td>Yes</td>
<td><p>Negative: Split dose</p>
<p>Positive: Graded dose</p></td>
</tr>
</tbody>
</table>
<table class="caption-top table">
<caption>Protocol for vaccine split dose administration</caption>
<colgroup>
<col style="width: 3%">
<col style="width: 40%">
<col style="width: 9%">
<col style="width: 37%">
<col style="width: 8%">
</colgroup>
<thead>
<tr class="header">
<th>Step</th>
<th>Volume (mL) of full-dose full-strength for 0.5 mL vaccine dose</th>
<th>Dilution</th>
<th>Percent of full-dose full-strength for 0.5 mL vaccine dose</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0.05</td>
<td>Full-strength</td>
<td>10%</td>
<td>30 minutes</td>
</tr>
<tr class="even">
<td>2</td>
<td>0.45</td>
<td>Full-strength</td>
<td>90%</td>
<td>30 minutes</td>
</tr>
</tbody>
</table>
<table class="caption-top table">
<caption>Protocol for vaccine graded dose administration</caption>
<colgroup>
<col style="width: 7%">
<col style="width: 15%">
<col style="width: 18%">
<col style="width: 43%">
<col style="width: 15%">
</colgroup>
<thead>
<tr class="header">
<th>Step</th>
<th>Volume (mL)</th>
<th>Dilution</th>
<th>Percent of full-dose full-strength</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0.05</td>
<td>1:10</td>
<td>N/A</td>
<td>15 minutes</td>
</tr>
<tr class="even">
<td>2</td>
<td>0.05</td>
<td>Full-strength</td>
<td>10%</td>
<td>15 minutes</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0.1</td>
<td>Full-strength</td>
<td>20%</td>
<td>15 minutes</td>
</tr>
<tr class="even">
<td>4</td>
<td>0.15</td>
<td>Full-strength</td>
<td>30%</td>
<td>15 minutes</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0.2</td>
<td>Full-strength</td>
<td>40%</td>
<td>15 minutes</td>
</tr>
</tbody>
</table>


</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
    var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
    var mailtoRegex = new RegExp(/^mailto:/);
      var filterRegex = new RegExp("https:\/\/tb4i\.mattkrantz\.com\/");
    var isInternal = (href) => {
        return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
    }
    // Inspect non-navigation links and adorn them if external
 	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool)');
    for (var i=0; i<links.length; i++) {
      const link = links[i];
      if (!isInternal(link.href)) {
        // undo the damage that might have been done by quarto-nav.js in the case of
        // links that we want to consider external
        if (link.dataset.originalHref !== undefined) {
          link.href = link.dataset.originalHref;
        }
      }
    }
  function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
    const config = {
      allowHTML: true,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start',
    };
    if (contentFn) {
      config.content = contentFn;
    }
    if (onTriggerFn) {
      config.onTrigger = onTriggerFn;
    }
    if (onUntriggerFn) {
      config.onUntrigger = onUntriggerFn;
    }
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      if (note) {
        return note.innerHTML;
      } else {
        return "";
      }
    });
  }
  const xrefs = window.document.querySelectorAll('a.quarto-xref');
  const processXRef = (id, note) => {
    // Strip column container classes
    const stripColumnClz = (el) => {
      el.classList.remove("page-full", "page-columns");
      if (el.children) {
        for (const child of el.children) {
          stripColumnClz(child);
        }
      }
    }
    stripColumnClz(note)
    if (id === null || id.startsWith('sec-')) {
      // Special case sections, only their first couple elements
      const container = document.createElement("div");
      if (note.children && note.children.length > 2) {
        container.appendChild(note.children[0].cloneNode(true));
        for (let i = 1; i < note.children.length; i++) {
          const child = note.children[i];
          if (child.tagName === "P" && child.innerText === "") {
            continue;
          } else {
            container.appendChild(child.cloneNode(true));
            break;
          }
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(container);
        }
        return container.innerHTML
      } else {
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        return note.innerHTML;
      }
    } else {
      // Remove any anchor links if they are present
      const anchorLink = note.querySelector('a.anchorjs-link');
      if (anchorLink) {
        anchorLink.remove();
      }
      if (window.Quarto?.typesetMath) {
        window.Quarto.typesetMath(note);
      }
      // TODO in 1.5, we should make sure this works without a callout special case
      if (note.classList.contains("callout")) {
        return note.outerHTML;
      } else {
        return note.innerHTML;
      }
    }
  }
  for (var i=0; i<xrefs.length; i++) {
    const xref = xrefs[i];
    tippyHover(xref, undefined, function(instance) {
      instance.disable();
      let url = xref.getAttribute('href');
      let hash = undefined; 
      if (url.startsWith('#')) {
        hash = url;
      } else {
        try { hash = new URL(url).hash; } catch {}
      }
      if (hash) {
        const id = hash.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note !== null) {
          try {
            const html = processXRef(id, note.cloneNode(true));
            instance.setContent(html);
          } finally {
            instance.enable();
            instance.show();
          }
        } else {
          // See if we can fetch this
          fetch(url.split('#')[0])
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.getElementById(id);
            if (note !== null) {
              const html = processXRef(id, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      } else {
        // See if we can fetch a full url (with no hash to target)
        // This is a special case and we should probably do some content thinning / targeting
        fetch(url)
        .then(res => res.text())
        .then(html => {
          const parser = new DOMParser();
          const htmlDoc = parser.parseFromString(html, "text/html");
          const note = htmlDoc.querySelector('main.content');
          if (note !== null) {
            // This should only happen for chapter cross references
            // (since there is no id in the URL)
            // remove the first header
            if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
              note.children[0].remove();
            }
            const html = processXRef(null, note);
            instance.setContent(html);
          } 
        }).finally(() => {
          instance.enable();
          instance.show();
        });
      }
    }, function(instance) {
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            div.style.left = 0;
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
        // Handle positioning of the toggle
    window.addEventListener(
      "resize",
      throttle(() => {
        elRect = undefined;
        if (selectedAnnoteEl) {
          selectCodeLines(selectedAnnoteEl);
        }
      }, 10)
    );
    function throttle(fn, ms) {
    let throttle = false;
    let timer;
      return (...args) => {
        if(!throttle) { // first call gets through
            fn.apply(this, args);
            throttle = true;
        } else { // all the others get throttled
            if(timer) clearTimeout(timer); // cancel #2
            timer = setTimeout(() => {
              fn.apply(this, args);
              timer = throttle = false;
            }, ms);
        }
      };
    }
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./delayed-drug-allergy.html" class="pagination-link" aria-label="Delayed Drug Allergy">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Delayed Drug Allergy</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./bioinformatic-best-practices.html" class="pagination-link" aria-label="Bioinformatic Best Practices">
        <span class="nav-page-text">Bioinformatic Best Practices</span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
<p>Translational Bioinformatics for Immunogenomics was written by Matthew S. Krantz</p>
</div>   
    <div class="nav-footer-center">
      &nbsp;
    <div class="toc-actions d-sm-block d-md-none"><ul><li><a href="https://github.com/mattkrantz/tb4i/edit/main/specific-drugs.qmd" class="toc-action"><i class="bi bi-github"></i>Edit this page</a></li><li><a href="https://github.com/mattkrantz/tb4i/issues/new" class="toc-action"><i class="bi empty"></i>Report an issue</a></li></ul></div></div>
    <div class="nav-footer-right">
<p>This book was built with <a href="https://quarto.org/">Quarto</a>.</p>
</div>
  </div>
</footer>




</body></html>